XML 63 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Common Stock and Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Reconciliation of the changes in the number of shares of common stock issued
A reconciliation of the changes in the number of common shares issued is as follows:
(Thousands)
 
 Number of Shares
Issued as of January 1, 2012
 
27,024

Exercise of stock options and stock appreciation rights (SARs)
 
26

Issued as of December 31, 2012
 
27,050

Exercise of stock options and SARs
 
114

Issued as of December 31, 2013
 
27,164

Exercise of stock options and SARs
 
62

Issued as of December 31, 2014
 
27,226

 
 
 
Summary of company's stock option activity
The following table summarizes the Company’s stock option activity during 2014:
(Shares in thousands)
 
Number of
Options
 
Weighted-
average
Exercise
Price Per
Share
 
Aggregate
Intrinsic
Value
 
Weighted-
average
Remaining
Term (Years)
Outstanding at December 31, 2013
 
21

 
$
17.29

 
$
—

 
—
Exercised
 
(20
)
 
17.29

 
—

 
—
Canceled
 
(1
)
 
17.08

 
—

 
—
Outstanding at December 31, 2014
 
—

 


 
—

 
—
Vested and expected to vest as of December 31, 2014
 
—

 


 
—

 
—
Exercisable at December 31, 2014
 
—

 


 
—

 
—
Summary of restricted stock activity
The following table summarizes the restricted stock activity during 2014:
(Shares in thousands)
 
Number of
Shares
 
Weighted-
average
Grant Date
Fair Value
Outstanding at December 31, 2013
 
200

 
$
32.71

Granted
 
60

 
33.29

Vested
 
(81
)
 
33.21

Forfeited
 
(27
)
 
33.21

Outstanding at December 31, 2014
 
152

 
$
30.76

Summary of stock activity for the directors deferred compensation plan
The following table summarizes the stock activity for the directors' deferred compensation plan during 2014:
(Shares in thousands)
 
Number of
Shares
 
Weighted-
average
Grant  Date
Fair Value
Outstanding at December 31, 2013
 
101

 
$
23.74

Granted
 
19

 
33.46

Outstanding at December 31, 2014
 
120

 
$
25.33

Summary of Company's SARs activity
The following table summarizes the Company's SARs activity during 2014:
(Shares in thousands)
 
Number of
SARs
 
Weighted-
average
Exercise
Price Per
Share
 
Aggregate
Intrinsic
Value
 
Weighted-
average
Remaining
Term (Years)
Outstanding at December 31, 2013
 
984

 
$
26.34

 
$
—

 
—
Granted
 
143

 
33.29

 
—

 
—
Exercised
 
(154
)
 
20.15

 
—

 
—
Cancelled
 
(5
)
 
33.30

 
—

 
—
Outstanding at December 31, 2014
 
968

 
28.32

 
7,633,000

 
4.4
Vested and expected to vest as of December 31, 2014
 
968

 
28.32

 
7,633,000

 
4.4
Exercisable at December 31, 2014
 
504

 
26.51

 
5,334,000

 
3.6
Summary of information on SARs outstanding
Summarized information on SARs outstanding as of December 31, 2014 follows:
                                         SARs Prices
 
Number
Outstanding
(Thousands)
 
Weighted-
average
Remaining
Life (Years)
 
Weighted-
average
Exercise
Price
$15.01
162

 
3.7
 
$
15.01

$21.24-$24.03
140

 
4.4
 
21.40

$27.78-$29.45
337

 
4.5
 
28.90

$33.30-$34.70
146

 
6.3
 
33.32

$39.30-$44.72
183

 
3.1
 
40.41

 
 
968

 
4.4
 
$
28.32

Fair value of SARs using Black-Scholes pricing model
The fair value of the SARs was estimated on the grant date using the Black-Scholes pricing model with the following assumptions:
 
 
2014

2013
 
2012
Risk-free interest rate
 
1.64
%

0.70
%
 
0.89
%
Dividend yield
 
1.0
%

1.1
%
 
—
%
Volatility
 
45.5
%

56.6
%
 
50.0
%
Expected lives (in years)
 
5.0


5.0

 
5.0